Selected research
Industry Research
Charcot-Marie-Tooth Disease Type I A Drug Industry Research Report 2026
Market perspective
The global Charcot-Marie-Tooth Disease Type I A Drug market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Charcot-Marie-Tooth Disease Type I A Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Charcot-Marie-Tooth Disease Type I A Drug is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Charcot-Marie-Tooth Disease Type I A Drug is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Charcot-Marie-Tooth Disease Type I A Drug include Pharnext SA, Lead Discovery Center GmbH, Genzyme Corp, Affectis Pharmaceuticals AG and Addex Therapeutics Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Charcot-Marie-Tooth Disease Type I A Drug market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Charcot-Marie-Tooth Disease Type I A Drug Market by Company
Pharnext SA
Lead Discovery Center GmbH
Genzyme Corp
Affectis Pharmaceuticals AG
Addex Therapeutics Ltd
Charcot-Marie-Tooth Disease Type I A Drug Segment by Type
ADX-71441
AFC-5128
Others
Charcot-Marie-Tooth Disease Type I A Drug Segment by Application
Hospital
Clinic
Others
Charcot-Marie-Tooth Disease Type I A Drug Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Charcot-Marie-Tooth Disease Type I A Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Charcot-Marie-Tooth Disease Type I A Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Charcot-Marie-Tooth Disease Type I A Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Charcot-Marie-Tooth Disease Type I A Drug manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Charcot-Marie-Tooth Disease Type I A Drug by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Charcot-Marie-Tooth Disease Type I A Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- ADX-71441
- AFC-5128
- Others
Applications
- Hospital
- Clinic
- Others
Companies covered
- Pharnext SA
- Lead Discovery Center GmbH
- Genzyme Corp
- Affectis Pharmaceuticals AG
- Addex Therapeutics Ltd
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Charcot-Marie-Tooth Disease Type I A Drug Market Size (2021-2032)
- 2.2.2 Global Charcot-Marie-Tooth Disease Type I A Drug Sales (2021-2032)
- 2.2.3 Global Charcot-Marie-Tooth Disease Type I A Drug Market Average Price (2021-2032)
- 2.3 Charcot-Marie-Tooth Disease Type I A Drug by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 ADX-71441
- 2.3.3 AFC-5128
- 2.3.4 Others
- 2.4 Charcot-Marie-Tooth Disease Type I A Drug by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Charcot-Marie-Tooth Disease Type I A Drug Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Charcot-Marie-Tooth Disease Type I A Drug Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Charcot-Marie-Tooth Disease Type I A Drug Revenue of Manufacturers (2021-2026)
- 3.4 Global Charcot-Marie-Tooth Disease Type I A Drug Average Price by Manufacturers (2021-2026)
- 3.5 Global Charcot-Marie-Tooth Disease Type I A Drug Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Charcot-Marie-Tooth Disease Type I A Drug, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Charcot-Marie-Tooth Disease Type I A Drug, Product Type & Application
- 3.8 Global Manufacturers of Charcot-Marie-Tooth Disease Type I A Drug, Established Date
- 3.9 Global Charcot-Marie-Tooth Disease Type I A Drug Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Pharnext SA
- 4.1.1 Pharnext SA Company Information
- 4.1.2 Pharnext SA Business Overview
- 4.1.3 Pharnext SA Charcot-Marie-Tooth Disease Type I A Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Pharnext SA Charcot-Marie-Tooth Disease Type I A Drug Product Portfolio
- 4.1.5 Pharnext SA Recent Developments
- 4.2 Lead Discovery Center GmbH
- 4.2.1 Lead Discovery Center GmbH Company Information
- 4.2.2 Lead Discovery Center GmbH Business Overview
- 4.2.3 Lead Discovery Center GmbH Charcot-Marie-Tooth Disease Type I A Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Lead Discovery Center GmbH Charcot-Marie-Tooth Disease Type I A Drug Product Portfolio
- 4.2.5 Lead Discovery Center GmbH Recent Developments
- 4.3 Genzyme Corp
- 4.3.1 Genzyme Corp Company Information
- 4.3.2 Genzyme Corp Business Overview
- 4.3.3 Genzyme Corp Charcot-Marie-Tooth Disease Type I A Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Genzyme Corp Charcot-Marie-Tooth Disease Type I A Drug Product Portfolio
- 4.3.5 Genzyme Corp Recent Developments
- 4.4 Affectis Pharmaceuticals AG
- 4.4.1 Affectis Pharmaceuticals AG Company Information
- 4.4.2 Affectis Pharmaceuticals AG Business Overview
- 4.4.3 Affectis Pharmaceuticals AG Charcot-Marie-Tooth Disease Type I A Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Affectis Pharmaceuticals AG Charcot-Marie-Tooth Disease Type I A Drug Product Portfolio
- 4.4.5 Affectis Pharmaceuticals AG Recent Developments
- 4.5 Addex Therapeutics Ltd
- 4.5.1 Addex Therapeutics Ltd Company Information
- 4.5.2 Addex Therapeutics Ltd Business Overview
- 4.5.3 Addex Therapeutics Ltd Charcot-Marie-Tooth Disease Type I A Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Addex Therapeutics Ltd Charcot-Marie-Tooth Disease Type I A Drug Product Portfolio
- 4.5.5 Addex Therapeutics Ltd Recent Developments
5 Global Charcot-Marie-Tooth Disease Type I A Drug Market Scenario by Region
- 5.1 Global Charcot-Marie-Tooth Disease Type I A Drug Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Charcot-Marie-Tooth Disease Type I A Drug Sales by Region: 2021-2032
- 5.2.1 Global Charcot-Marie-Tooth Disease Type I A Drug Sales by Region: 2021-2026
- 5.2.2 Global Charcot-Marie-Tooth Disease Type I A Drug Sales by Region: 2027-2032
- 5.3 Global Charcot-Marie-Tooth Disease Type I A Drug Revenue by Region: 2021-2032
- 5.3.1 Global Charcot-Marie-Tooth Disease Type I A Drug Revenue by Region: 2021-2026
- 5.3.2 Global Charcot-Marie-Tooth Disease Type I A Drug Revenue by Region: 2027-2032
- 5.4 North America Charcot-Marie-Tooth Disease Type I A Drug Market Facts & Figures by Country
- 5.4.1 North America Charcot-Marie-Tooth Disease Type I A Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Charcot-Marie-Tooth Disease Type I A Drug Sales by Country (2021-2032)
- 5.4.3 North America Charcot-Marie-Tooth Disease Type I A Drug Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Charcot-Marie-Tooth Disease Type I A Drug Market Facts & Figures by Country
- 5.5.1 Europe Charcot-Marie-Tooth Disease Type I A Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Charcot-Marie-Tooth Disease Type I A Drug Sales by Country (2021-2032)
- 5.5.3 Europe Charcot-Marie-Tooth Disease Type I A Drug Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Charcot-Marie-Tooth Disease Type I A Drug Market Facts & Figures by Country
- 5.6.1 Asia Pacific Charcot-Marie-Tooth Disease Type I A Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Charcot-Marie-Tooth Disease Type I A Drug Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Charcot-Marie-Tooth Disease Type I A Drug Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Charcot-Marie-Tooth Disease Type I A Drug Market Facts & Figures by Country
- 5.7.1 South America Charcot-Marie-Tooth Disease Type I A Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Charcot-Marie-Tooth Disease Type I A Drug Sales by Country (2021-2032)
- 5.7.3 South America Charcot-Marie-Tooth Disease Type I A Drug Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Charcot-Marie-Tooth Disease Type I A Drug Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Charcot-Marie-Tooth Disease Type I A Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Charcot-Marie-Tooth Disease Type I A Drug Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Charcot-Marie-Tooth Disease Type I A Drug Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Charcot-Marie-Tooth Disease Type I A Drug Sales by Type (2021-2032)
- 6.1.1 Global Charcot-Marie-Tooth Disease Type I A Drug Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Charcot-Marie-Tooth Disease Type I A Drug Sales Market Share by Type (2021-2032)
- 6.2 Global Charcot-Marie-Tooth Disease Type I A Drug Revenue by Type (2021-2032)
- 6.2.1 Global Charcot-Marie-Tooth Disease Type I A Drug Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Charcot-Marie-Tooth Disease Type I A Drug Revenue Market Share by Type (2021-2032)
- 6.3 Global Charcot-Marie-Tooth Disease Type I A Drug Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Charcot-Marie-Tooth Disease Type I A Drug Sales by Application (2021-2032)
- 7.1.1 Global Charcot-Marie-Tooth Disease Type I A Drug Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Charcot-Marie-Tooth Disease Type I A Drug Sales Market Share by Application (2021-2032)
- 7.2 Global Charcot-Marie-Tooth Disease Type I A Drug Revenue by Application (2021-2032)
- 7.2.1 Global Charcot-Marie-Tooth Disease Type I A Drug Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Charcot-Marie-Tooth Disease Type I A Drug Revenue Market Share by Application (2021-2032)
- 7.3 Global Charcot-Marie-Tooth Disease Type I A Drug Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Charcot-Marie-Tooth Disease Type I A Drug Value Chain Analysis
- 8.1.1 Charcot-Marie-Tooth Disease Type I A Drug Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Charcot-Marie-Tooth Disease Type I A Drug Production Mode & Process
- 8.2 Charcot-Marie-Tooth Disease Type I A Drug Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Charcot-Marie-Tooth Disease Type I A Drug Distributors
- 8.2.3 Charcot-Marie-Tooth Disease Type I A Drug Customers
9 Global Charcot-Marie-Tooth Disease Type I A Drug Analyzing Market Dynamics
- 9.1 Charcot-Marie-Tooth Disease Type I A Drug Industry Trends
- 9.2 Charcot-Marie-Tooth Disease Type I A Drug Industry Drivers
- 9.3 Charcot-Marie-Tooth Disease Type I A Drug Industry Opportunities and Challenges
- 9.4 Charcot-Marie-Tooth Disease Type I A Drug Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst